These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


147 related items for PubMed ID: 43404

  • 1. [Cardiovascular effects of propanolol, alprenolol, oxprenolol and CS-359 during halothane anesthesia (author's transl)].
    Kubota M, Gotho Y, Furukawa K.
    Masui; 1979 Aug; 28(8):797-804. PubMed ID: 43404
    [No Abstract] [Full Text] [Related]

  • 2. Comparison of beta-adrenergic blocking activities of propranolol, isopropylmethoxamine, sotalol, practolol, alprenolol, pindolol, oxprenolol and D-32 in the atria and trachea of the guinea-pig.
    Horii D, Kawada T, Takeda K, Imai S.
    Arzneimittelforschung; 1974 Sep; 24(9):1275-7. PubMed ID: 4154764
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The interactivities with lipid membranes differentially characterize selective and nonselective beta1-blockers.
    Mizogami M, Takakura K, Tsuchiya H.
    Eur J Anaesthesiol; 2010 Sep; 27(9):829-34. PubMed ID: 20601889
    [Abstract] [Full Text] [Related]

  • 10. Clinical pharmacological evaluation of beta-receptor antagonists. I. The effect of propranolol, oxprenolol, alprenolol on some central circulatory parameters in patients with essential circulatory hyperkinesis (ECH).
    Békés M, Matos L, Rausch J, Török E.
    Int J Clin Pharmacol; 1972 Jun; 6(2):161-6. PubMed ID: 4404774
    [No Abstract] [Full Text] [Related]

  • 11. [On the cardiovascular and beta-adrenergic blocking effects produced in the beagle dog by repeated oral administration of talinolol (Cordanum) and propranolol (author's transl)].
    Heer S, Femmer K.
    Pharmazie; 1980 Jun; 34(5-6):317-20. PubMed ID: 6106208
    [No Abstract] [Full Text] [Related]

  • 12. [Arrhythmia action and cardiovascular effects of a new beta-adrenergic blockader (Oxprenolol)].
    Suzuki K, Kubota M, Odashiro M, Yasuda K, Goto Y.
    Masui; 1972 Jan; 21(1):46-50. PubMed ID: 4401935
    [No Abstract] [Full Text] [Related]

  • 13. [Effects of Kö 1366 and propranolol on hemodynamics and regional myocardial blood flow in the selective coronary hypotensive dogs (author's transl)].
    Tomoike H.
    Fukuoka Igaku Zasshi; 1975 Apr; 66(4):301-19. PubMed ID: 237808
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Basis for the use of beta-receptor blockaders in the practice].
    Blankart R.
    Schweiz Rundsch Med Prax; 1973 Aug 07; 62(32):975-8. PubMed ID: 4147247
    [No Abstract] [Full Text] [Related]

  • 19. [Properties of beta-adrenergic receptors of heart and lung--studies with "cardioselective" beta-receptor blocking substances].
    Krawietz W, Weinsteiger M, Pruchniewski M, Erdmann E.
    Verh Dtsch Ges Kreislaufforsch; 1977 Aug 07; 43():414-5. PubMed ID: 26149
    [No Abstract] [Full Text] [Related]

  • 20. Hemodynamic effects of beta-adrenergic blockade with pindolol, oxprenolol, propranolol and bufetolol hydrochloride in essential hypertension.
    Tsukiyama H, Otsuka K, Miyamoto K, Hashimoto M, Yasutake S.
    Jpn Circ J; 1976 Jun 07; 40(6):655-64. PubMed ID: 7688
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.